These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34330556)

  • 1. Will COVID-19 vaccine equity be possible in India?
    Mathivathanan K
    Vaccine; 2021 Aug; 39(35):4928-4929. PubMed ID: 34330556
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine hesitancy among medical students in India.
    Jain J; Saurabh S; Kumar P; Verma MK; Goel AD; Gupta MK; Bhardwaj P; Raghav PR
    Epidemiol Infect; 2021 May; 149():e132. PubMed ID: 34011421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of COVID-19 Vaccination on Menstrual Cycle Patterns of Reproductive-age Women: A Multi-centric Observational Study.
    Kumar N; Gangane N; Mohapatra I; Rukadikar C; Sharmila V; Pushpalatha K; Eerike M; Santhoshi G; Samantaray SR; Seth S; Trigunait P; Reddy NJ; Patel S; Rani S; Mishra R; Negi K
    Curr Drug Res Rev; 2024; 16(2):237-248. PubMed ID: 37291775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital.
    Arankalle V; Kulkarni-Munje A; Kulkarni R; Palkar S; Patil R; Oswal J; Lalwani S; Mishra AC
    Front Immunol; 2022; 13():928501. PubMed ID: 36211366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study.
    Bhatnagar T; Chaudhuri S; Ponnaiah M; Yadav PD; Sabarinathan R; Sahay RR; Ahmed F; Aswathy S; Bhardwaj P; Bilimale A; Kumar MS; Logaraj M; Narlawar U; Palanivel C; Patel P; Rai SK; Saxena V; Singh A; Thangaraj JW; Agarwal A; Alvi Y; Amoghashree ; Ashok P; Babu D; Bahurupi Y; Bhalavi S; Behera P; Biswas PP; Charan J; Chauhan NK; Chetak KB; Dar L; Das A; Deepashree R; Dhar M; Dhodapkar R; Dipu TS; Dudeja M; Dudhmal M; Gadepalli R; Garg MK; Gayathri AV; Goel AD; Gowdappa HB; Guleria R; Gupta MK; Islam F; Jain M; Jain V; Jawahar MLS; Joshi R; Kant S; Kar SS; Kalita D; Khapre M; Khichar S; Kombade SP; Kohli S; Kumar A; Kumar A; Kumar D; Kulirankal KG; Leela KV; Majumdar T; Mishra B; Misra P; Misra S; Mohapatra PR; Murthy MN; Nyayanit DA; Patel M; Pathania M; Patil S; Patro BK; Jalandra R; Rathod P; Shah N; Shete A; Shukla D; Shwethashree M; Sinha S; Sumana MN; Surana A; Trikha A; Tejashree A; Venkateshan M; Vijaykrishnan G; Wadhava S; Wig N; Gupta N; Abraham P; Murhekar MV
    Int J Infect Dis; 2022 Sep; 122():693-702. PubMed ID: 35843496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield
    Singh AK; Phatak SR; Singh R; Bhattacharjee K; Singh NK; Gupta A; Sharma A
    Vaccine; 2021 Oct; 39(44):6492-6509. PubMed ID: 34600747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELD
    Dash GC; Subhadra S; Turuk J; Parai D; Rath S; Sabat J; Rout UK; Kanungo S; Choudhary HR; Nanda RR; Pattnaik M; Pati S; Bhattacharya D
    J Med Virol; 2022 Mar; 94(3):1201-1205. PubMed ID: 34622961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of the strategy and status of COVID-19 vaccination in India.
    Gupta SL; Goswami S; Anand A; Naman N; Kumari P; Sharma P; Jaiswal RK
    Immunol Res; 2023 Aug; 71(4):565-577. PubMed ID: 37041424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    Singh UB; Rophina M; Chaudhry R; Senthivel V; Bala K; Bhoyar RC; Jolly B; Jamshed N; Imran M; Gupta R; Aggarwal P; Divakar MK; Sinha S; Arvinden VR; Bajaj A; Shamnath A; Jain A; ; Scaria V; Sivasubbu S; Guleria R
    J Med Virol; 2022 Apr; 94(4):1696-1700. PubMed ID: 34786733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covishield India: demystifying myths through an early multicenter study.
    Mohakuda SS; Nigam A; Rajesh K; Sashindran VK; Sharma H; Singh B; Kaur R; Thawal M
    Am J Manag Care; 2021 Oct; 27(10):e339-e342. PubMed ID: 34668675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The initial experience of COVID-19 vaccination from a tertiary care centre of India.
    Srivastava RK; Ish P; Covid-Vaccination Group S
    Monaldi Arch Chest Dis; 2021 Mar; 91(4):. PubMed ID: 33794595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin.
    Kant R; Dwivedi G; Zaman K; Sahay RR; Sapkal G; Kaushal H; Nyayanit DA; Yadav PD; Deshpande G; Singh R; Chaowdhary S; Gupta N; Kumar S; Abraham P; Panda S; Bhargava B
    J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34652440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. India and the COVID-19 vaccine.
    Satish KP
    Hum Vaccin Immunother; 2022 Dec; 18(1):2033541. PubMed ID: 35191815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fake COVID-19 vaccines: scams hampering the vaccination drive in India and possibly other countries.
    Choudhary OP; Priyanka ; Singh I; Mohammed TA; Rodriguez-Morales AJ
    Hum Vaccin Immunother; 2021 Nov; 17(11):4117-4118. PubMed ID: 34357851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health.
    Sarkar MA; Ozair A; Singh KK; Subash NR; Bardhan M; Khulbe Y
    Ann Glob Health; 2021; 87(1):124. PubMed ID: 34963880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India - a community based survey.
    Danabal KGM; Magesh SS; Saravanan S; Gopichandran V
    BMC Health Serv Res; 2021 Sep; 21(1):994. PubMed ID: 34548088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination and Its Impact on Lung Involvement in COVID-19 Patients: A Retrospective Study in India.
    Balasubramaniam S; Bose P; Raviganesh PK; Pandian P; Selvaraj B; Sivaprakasam R; Balaji S; Am A; Sivakumar P; Ramasubramanian S
    Cureus; 2024 Apr; 16(4):e58904. PubMed ID: 38800182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study.
    Singh AK; Phatak SR; Singh R; Bhattacharjee K; Singh NK; Gupta A; Sharma A
    Diabetes Metab Syndr; 2022 Feb; 16(2):102424. PubMed ID: 35150961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.
    Mohanasundaram K; Santhanam S; Natarajan R; Murugesan H; Nambi T; Chilikuri B; Nallasivan S
    Int J Rheum Dis; 2022 Sep; 25(9):1046-1052. PubMed ID: 35773944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated vaccine Covaxin/BBV152: A systematic review.
    Ahmed TI; Rishi S; Irshad S; Aggarwal J; Happa K; Mansoor S
    Front Immunol; 2022; 13():863162. PubMed ID: 36016940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.